SYNTHON HISPANIA SL
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about SYNTHON HISPANIA SL
Live alerts from global media, monitored by Business Radar
2024-10-31 (bizportal.co.il)
The European Commission imposed a fine of half a billion euros on Teva for its conduct in the Copaxone market
According to the findings of the European Commission's investigation, Teva acted on several fronts to prevent competition in the copaxone market, even after the original patent expired
Read more
Used by 100+ compliance teams and analysts